Title:
【発明の名称】脳関連疾患、障害および傷害の治療のための刺激された末梢血単核細胞の使用
Document Type and Number:
Japanese Patent JP2002509942
Kind Code:
A
Abstract:
The invention relates to the use of stimulated peripheral blood mononuclear cells (PBMC) for the treatment of brain-related diseases, disorders and damage, such as manic-depressive illness or manic-depressive psychosis, schizophrenia, depressive syndromes without endogenous cause, autism, disturbances of cerebral development during and after the embryonal stage, Downs syndrome, brain damage due to accidents or other causes, and Parkinson's disease. After activation of the PMBC the stimulated cells can possibly also be treated with gamma-interferon and/or alpha-interferon.
Inventors:
Bank, Rudolph
Application Number:
JP2000541281A
Publication Date:
April 02, 2002
Filing Date:
March 31, 1999
Export Citation:
Assignee:
Bank, Rudolph
International Classes:
A61P25/14; A61P25/18; C12N5/0783; A61K35/12; (IPC1-7): A61K35/14; A61P25/14; A61P25/18; C12N5/06
Attorney, Agent or Firm:
Takashi Ishida (4 others)